This hypothesis is further supported by a recent study using the APP-PS1 model for AD, the ALS model SOD1G93A and an EAE model to investigate the role of the Trem2–Apoe complex in microglial dysfunction in neurodegeneration (96). This evidence concerns the gene TREM2 and Alzheimer disease.